Evidence map›Paper›PMID 33578631›Full record

ArticleCells2021

Molecular Insights into the Thrombotic and Microvascular Injury in Placental Endothelium of Women with Mild or Severe COVID-19.

Arturo Flores-Pliego, Jael Miranda, Sara Vega-Torreblanca, Yolotzin Valdespino-Vázquez, Cecilia Helguera-Repetto, Aurora Espejel-Nuñez, Héctor Borboa-Olivares, Salvador Espino Y Sosa, Paloma Mateu-Rogell, Moisés León-Juárez and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. The Highs and Lows of ADAMTS13 Activity.Journal of clinical medicine · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Arturo Flores-PliegoDepartment of Immunobiochemistry, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.ORCID 0000-0001-7876-6098
Jael MirandaDepartment of Physiology, Biophysics and Neuroscience, Center for Research and Advanced Studies (Cinvestav), Ciudad de México 07360, Mexico.ORCID 0000-0003-0122-5132
Sara Vega-TorreblancaDepartment of Physiology, Biophysics and Neuroscience, Center for Research and Advanced Studies (Cinvestav), Ciudad de México 07360, Mexico.
Yolotzin Valdespino-VázquezDepartment of Pathology, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Cecilia Helguera-RepettoDepartment of Immunobiochemistry, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.ORCID 0000-0001-6715-9671
Aurora Espejel-NuñezDepartment of Immunobiochemistry, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.ORCID 0000-0001-9087-8017
Héctor Borboa-OlivaresCommunity Interventions Research Branch, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Salvador Espino Y SosaClinical Research Branch, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Paloma Mateu-RogellClinical Research Branch, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Moisés León-JuárezDepartment of Immunobiochemistry, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.ORCID 0000-0002-5726-5953
Victor Ramírez-SantesDepartment of Obstetrics, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Arturo Cardona-PérezGeneral Direction, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Isabel Villegas-MotaDepartment of Epidemiology, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.
Johnatan Torres-TorresHospital General de México Dr Eduardo Liceaga, Ciudad de México 06720, Mexico.ORCID 0000-0002-9524-4133
Ángeles Juárez-ReyesHospital General de México Dr Eduardo Liceaga, Ciudad de México 06720, Mexico.
Thelma Rizo-PicaHospital General de México Dr Eduardo Liceaga, Ciudad de México 06720, Mexico.
Rosa O GonzálezDepartment of Mathematics, Autonomous Metropolitan University-Iztapalapa (UAM-I), Ciudad de México 14387, Mexico.
Lorenza González-MariscalDepartment of Physiology, Biophysics and Neuroscience, Center for Research and Advanced Studies (Cinvestav), Ciudad de México 07360, Mexico.
Guadalupe Estrada-GutierrezResearch Division, Instituto Nacional de Perinatología, Ciudad de México 11000, Mexico.ORCID 0000-0001-9551-9021
Instituto Nacional de Perinatología · MXCentro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional · MXHospital General de México · MXUniversidad Autónoma Metropolitana · MX

Funding

Cinvestav, and by SEP-Cinvestav FIDSC2018/33Instituto Nacional de Perinatología 2020-1-32
6 · The paper itself

Abstract

Clinical manifestations of coronavirus disease 2019 (COVID-19) in pregnant women are diverse, and little is known of the impact of the disease on placental physiology. Severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been detected in the human placenta, and its binding receptor ACE2 is present in a variety of placental cells, including endothelium. Here, we analyze the impact of COVID-19 in placental endothelium, studying by immunofluorescence the expression of von Willebrand factor (vWf), claudin-5, and vascular endothelial (VE) cadherin in the decidua and chorionic villi of placentas from women with mild and severe COVID-19 in comparison to healthy controls. Our results indicate that: (1) vWf expression increases in the endothelium of decidua and chorionic villi of placentas derived from women with COVID-19, being higher in severe cases; (2) Claudin-5 and VE-cadherin expression decrease in the decidua and chorionic villus of placentas from women with severe COVID-19 but not in those with mild disease. Placental histological analysis reveals thrombosis, infarcts, and vascular wall remodeling, confirming the deleterious effect of COVID-19 on placental vessels. Together, these results suggest that placentas from women with COVID-19 have a condition of leaky endothelium and thrombosis, which is sensitive to disease severity.

Indexed as

AdultAntigens, CDCadherin 5CadherinsClaudin-5COVID-19EndotheliumFemaleHumansInfant, NewbornMicrovesselsPlacentaPregnancyPregnancy Complications, CardiovascularPregnancy Complications, InfectiousSARS-CoV-2Antigens, CDCadherin 5CadherinsClaudin-5CLDN5 protein, humanvon Willebrand Factorclaudin-5COVID-19endotheliumplacentaVE-cadherinvon Willebrand factor

Identifiers

PMID33578631
PMCPMC7916402
OpenAlexW3127897547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.